IFNG (+874 T/A) polymorphism and cervical intraepithelial Neoplasia in Brazilian women

Journal of Interferon and Cytokine Research

Volumn 29, Issue 5, 2009, Pages 285-288

  Von Linsingen, Renate ^a   Bompeixe, Eni P ^a   Maestri, Carlos A ^b   Carvalho, Newton S ^a   Da Graa Bicalho, Maria ^a,c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Lower Genital Tract Diseases Section Erasto Gaertner Hospital   (Brazil)

^c UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; BRAZIL; CANCER GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC DIFFERENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ALLELES; BRAZIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; INTERFERON-GAMMA; POLYMORPHISM, GENETIC;

HUMAN PAPILLOMAVIRUS;

EID: 66749126781     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0081     Document Type: Article

References (25)

1. Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E. 1997. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89:245-250.
2. Clerici M, Shearer GM, Clerici E. 1998. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst 90:261-263.
3. Govan VA, Constant D, Hoffman M, Williamson AL. 2006. The al-lelic distribution of -308 Tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6:24.
4. Helmerhorst TJ, Meijer CJ. 2002. Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD. Int J Gynecol Cancer 12:235-236.
5. INCA. 2008. MdS. Rio de Janeiro, Brazil: Incidencia de Cancer no Brasil.
6. Jacobs N, Giannini SL, Doyen J, Baptista A, Moutschen M, Boniver J, Delvenne P. 1998. Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin Exp Immunol 111:219-224.
7. Kjaer SK, Chackerian B, van den Brule AJ, Svare El, Paull G, Walbomer s JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL. 2001. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101-106.
8. Lahiri DK, Nurnberger JI Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
9. Moscicki AB, Ellenberg JH, Farhat S, Xu J. 2004. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 190:37-45.
10. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
11. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20-25.
12. Pacheco AG, Cardoso CC, Moraes MO. 2008. IFNG +874T/A, IL10-1082G/A and TNF-308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum Genet 123:477-484.
13. Pao CC, Lin CY, Yao DS, Tseng CJ. 1995. Differential expression of cytokine genes in cervical cancer tissues. Biochem Biophys Res Commun 214:1146-1151.
14. Pardo-Govea T, Callejas D, Nunez-Troconis J, Araujo M, Costa L, Pons H, Delgado M, Monsalve F. 2005. Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2,4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neo-plasia: a preliminary report. Invest Clin 46:5-13.
15. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
16. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. 2000. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863-866.
17. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos, MM. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958-964.
18. Scott M, Stites DP, Moscicki AB. 1999. Thl cytokine patterns in cervical human papillomavirus infection. Clin Diagn Labs Immunol 6:751-755.
19. Song SH, Lee JK, Lee NW, Saw HS, Kang JS, Lee KW. 2008. Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV). Gynecol Oncol 108:543-548.
20. Southern SA, Herrington CS. 1998. Molecular events in uterine cervical cancer. Sex Transm Infect 74:101-109.
21. Souza ER 2004. Epidemiologia da infeção genital por HPV e anor-malidades na citologia cervical em mulheres jovens brasileiras. Doctorate.
22. Spellberg B, Edwards JE Jr. 2001. Type I/Type 2 immunity in infectious diseases. Clin Infect Dis 32:76-102.
23. Suri D, Schilling R, Lopes AR, Mullerova I, Colucci G, Williams R, Naoumov NV 2001. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J Hepatol 35:790-797.
24. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
25. Wu TC, Kurman RJ. 1997. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J Natl Cancer Inst 89:185-187.